glp 1 drugs shortage The GLP-1 drug is over. What's next for the compounders? - Pharma Technology Focus | Issue 154 The weight loss drug shortage
Description
The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others
Previous research has shown that GLP1 (936) can decrease levels of IL-1 , interleukin 6 (IL-6), and tumor necrosis factor- (TNF-)
Trends Endocrinol Metab 31(6):410421
In a partial hepatectomy-induced behavior study using male Sprague-Dawley rats, surgical trauma induced an exacerbated spatial learning and memory impairment, while exendin-4 treatment suppressed the activation of nuclear factor kappa-B (NF-B) and IL-1, and thus ameliorated hepatectomy-induced behavioral deficits and inflmmation (63)
10.1002/oby.23673
